日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Conversion following minimally invasive attempt at simultaneous colorectal and liver resection does not affect 30-day postoperative overall morbidity

微创尝试同时进行结直肠和肝脏切除术后转为开腹手术,不会影响术后30天的总体发病率。

Brown, Lawrence B; Radomski, Shannon N; Stem, Miloslawa; Gearhart, Susan L; Chung, Haniee; Obias, Vincent J; Gabre-Kidan, Alodia

Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer

直肠癌序贯短期放疗和化疗后的手术及局部控制结果

Liu, I-Chia; Gearhart, Susan; Ke, Suqi; Hu, Chen; Chung, Haniee; Efron, Jonathan; Gabre-Kidan, Alodia; Najjar, Peter; Atallah, Chady; Safar, Bashar; Christenson, Eric S; Azad, Nilofer S; Lee, Valerie; Zaheer, Atif; Birkness-Gartman, Jacqueline E; Reddy, Abhinav V; Narang, Amol K; Meyer, Jeffrey

National trends and feasibility of a robotic surgical approach in the management of patients with inflammatory bowel disease

全国范围内采用机器人手术方法治疗炎症性肠病患者的趋势和可行性

Radomski, Shannon N; Stem, Miloslawa; Consul, Michael; Maturi, Jay Rammohan; Chung, Haniee; Gearhart, Susan; Graham, Ada; Obias, Vincent J

Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma

以CD47为靶点的抗体介导疗法可抑制肝细胞癌的肿瘤进展

Zhenyu Xiao,Haniee Chung,Babak Banan,Pamela T Manning,Katherine C Ott,Shin Lin,Benjamin J Capoccia,Vijay Subramanian,Ronald R Hiebsch,Gundumi A Upadhya,Thalachallour Mohanakumar,William A Frazier,Yiing Lin,William C Chapman

Liver transplantation for hepatocellular carcinoma: how far have we come and what is the future?

肝细胞癌的肝移植:我们取得了哪些进展,未来又将如何发展?

Chung, Haniee; Chapman, William C

IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis

IFNgamma 通过调节 STAT1、IFN 调节因子 1、NF-kappaB、BCL2 家族成员以及向 caspase 依赖性细胞凋亡发出信号,恢复乳腺癌对氟维司群的敏感性

Yanxia Ning, Rebecca B Riggins, Jennifer E Mulla, Haniee Chung, Alan Zwart, Robert Clarke